Erika Ortolan
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Utility of combined CD39/CD73/CD38 expression for the detection of malignant T cells in Sézary syndrome.
Journal: British journal of haematology
Published: February 05, 2026
The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas.
Journal: Cells
Published: January 05, 2025
Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects.
Journal: Frontiers in immunology
Published: October 29, 2024
Monitoring circulating tumor DNA liquid biopsy in stage III BRAF-mutant melanoma patients undergoing adjuvant treatment.
Journal: Journal of translational medicine
Published: August 29, 2024
Spinocerebellar ataxia 38: structure-function analysis shows ELOVL5 G230V is proteotoxic, conformationally altered and a mutational hotspot.
Journal: Human genetics
Published: February 22, 2023
CD157 signaling promotes survival of acute myeloid leukemia cells and modulates sensitivity to cytarabine through regulation of anti-apoptotic Mcl-1.
Journal: Scientific reports
Published: July 28, 2021
CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study.
Journal: Disease markers
Published: July 28, 2021
CD157: From Myeloid Cell Differentiation Marker to Therapeutic Target in Acute Myeloid Leukemia.
Journal: Cells
Published: October 24, 2019
CD157: From immunoregulatory protein to potential therapeutic target.
Journal: Immunology letters
Published: April 18, 2018
Last Updated: 09/26/2026